期刊文献+

奥沙拉嗪治疗溃疡性结肠炎80例临床分析 被引量:3

Salad qin treatment ulcerous colitis 80 example clinical analysis
原文传递
导出
摘要 目的:探讨奥沙拉嗪治疗溃疡性结肠炎(UC)的临床效果.方法:选择80例UC患者,随机分为治疗组和对照组各40例,治疗组用奥沙拉嗪治疗,对照组用柳氮磺胺吡啶治疗,比较两组疗效和不良反应.结果:治疗组总有效率为77.5%,对照组为67.5%,两组疗效相近,差异无统计学意义(P〉0.05);治疗组不良反应发生率为10%,对照组不良反应发生率为22.5%,差异显著(P〈0.05).结论:奥沙拉嗪治疗溃疡性结肠炎与柳氮磺胺吡啶相近,但不良反应少,更适宜在临床应用. Objective: Discusses Austria salad qin treatment ulcerous colitis (UC) the clinical effect. Methods:Chooses 80 example UC patient, divides into the treatment group and control group each 40 examples stochastically,the treatment group with the Austria salad qin treatment,the control group with the willow tree nitrogen sulfidin sulfanilylpyridine treatment,and responded not good compared with two groups of curative effects. Results:Treatment group total effectiveness is 77.5%, the control group is 67.5%, two groups of curative effects is close,difference non--statistics significance (P〉0. 05) ;The treatment group responded not good the formation rate is 10 %,the control group responded not good the formation rate is 22.5%, difference remarkable (P〈0.05). Conclusion: The Austria salad qin treatment ulcerous colitis and the willow tree nitrogen sutfidin sulfanilylpyridine is close, but responds not good few,is suitable in the clinical practice.
作者 高建民
出处 《按摩与康复医学》 2011年第2期240-241,共2页 Chinese Manipulation and Rehabilitation Medicine
关键词 奥沙拉嗪 溃疡性结肠炎 柳氮磺胺吡啶 Austria salad qin Ulcerous colitis Willow tree nitrogen sulfidin sulfanilylpyridine
  • 相关文献

参考文献3

二级参考文献25

  • 1潘国宗 刘彤华 见:潘国宗 曹世植9. 主编.溃疡性结肠炎[A].见:潘国宗,曹世植9.,主编.现代胃肠病学.第Ⅰ版[C].北京:科学出版社,1994.1246-1247. 被引量:5
  • 2潘国宗 刘彤华.Crohn病[A].见:潘国宗 曹世植 主编.现代胃肠病学[C].北京:科学出版社,1994.1154. 被引量:3
  • 3Hanauer S,Schwartz J,Robinson M,et al.Mesalamine capsules for treatment of active ulcerative colitis[J].Am J Gastroenterol,1993,88:1188~1197. 被引量:1
  • 4Sutherland L,May G,Shaffer E.Sulfasalaine revisited:A meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis[J].Ann Zntern Med,1993,118:540~542. 被引量:1
  • 5Ardzzone S,Doldo P,Ranzi T,et al.Mesalazine foam(salofalk foam)in the treatment of active distal ulcerative colitis:A comarative trial vs salofal kenema.The SAF-3 study group[J].Ital J Gastroenterol Hepatol,1999,31:677~679. 被引量:1
  • 6Munakata A,Yoshida Y,Muto T,et al.Double-bulined comparative study of sulfasalazine and controlled-release mesalazine tablets in the treatment of active ulcerative colitis[J].J Gastroenterol,1995,30(suppl 8):108~111. 被引量:1
  • 7Riley SA,Mani V,Goodmen MJ,et al.Comparison of delayed release 5-aminosalicylic acid(mesalazine) and sulfalazine as mainlenance treatment for patients with ulcerative colitis[J].Gastroenterology,1988,94:1383~1389. 被引量:1
  • 8Schroeder KW.Role of mesalazine in acute and long-term treatment of ulcerative colitis and its complication[J].Scand J Gastroenterol,2002(suppl 236):42~44. 被引量:1
  • 9Fernander J,Sala M,Panes J,et al.Acute pancreatitis after long-term 5-aminosalicylic acid therapy[J].Am J Gastroenterol,1997,92:2302~2305. 被引量:1
  • 10Ouyang Q,Tandon R,Goh KL,et al.The emergence of inflammatory bowel disease in the Asian Pacific region.Curr Opin Gastroenterol,2005,21 (4):408-413. 被引量:1

共引文献1837

同被引文献16

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部